ALO-02
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Proper management of severe pain represents one of the most challenging clinical dilemmas. Two equally important goals must be…
BackgroundThe efficacy of ALO-02, an abuse-deterrent formulation containing extended-release oxycodone and sequestered naltrexone…
Abstract Objective. To evaluate the abuse potential of ALO-02, an abuse-deterrent formulation comprising pellets of extended…
ABSTRACT Background: ALO-02, comprising pellets of extended-release oxycodone surrounding sequestered naltrexone, is intended to…
Abstract The objective of this multicenter, double-blind, placebo-controlled, randomized withdrawal study was to evaluate the…
ALO‐02 is an abuse‐deterrent formulation consisting of capsules filled with pellets of extended‐release oxycodone surrounding…
Background and ObjectivesALO-02 capsules, intended to deter abuse, contain pellets of extended-release oxycodone hydrochloride…
Abstract Background: For properly selected patients experiencing chronic pain, extended-release opioid formulations may represent…
OBJECTIVE
To evaluate the long-term safety of oxycodone-hydrochloride and sequestered naltrexone-hydrochloride (ALO-02…
Background: ALO-02, an opioid formulation intended to deter abuse, comprising capsules filled with pellets of extended-release…